Enhanced inflammation and IR are found in patients with HCC, evidenced by elevated levels of pro-inflammatory cytokines such as interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and C-reactive protein (Aleksandrova et al., 2014; Duan et al., 2022). Here, TNF is linked to hepatocellular carcinoma.